Atlas Trials

The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

Clinical trial NCT05919147 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05919147
Sponsor
Pennington Biomedical Research Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2024-01-03
Primary completion
2025-06-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.